Research - Yavne, Center District, Israel
Focus: Development of platform technology for manufacture of medical grade cannabinoidsMission: Develop drugs for unmet needs using state-of-art medical grade cannabinoids API manufactured by proprietary processes of biosynthesis and biocatalysis (not plant extract)Current status: Expression system definedDNA plasmid preparation in processExpression process develpopment planned for Q3 2017BackgroundEnzymogen uses enzymatic processes to convert natural resources into commercially viable products. Our expertise includes utilizing enzymes to improve yield and efficiency of existing products while maximizing the possibility of creating commercially viable byproducts. Enzymogen's core functions include:• Full package projects- from clone to final enzyme product• Custom project design • Clone development in mammalian, bacterial, yeast & algae • Proprietary directed evolution process• Process development & optimization- expression, purification, formulation• Fermenter/bioreactor scale up• Establishment of analytical methods for in-process and release testing• GMP manufacturingOur current product offering includes:• Taq DNA polymerase (non bacterial source)• Human gastric lipase• Phospholipase C• Phospholipase D• Cholesterol esterase (YEH1)• Cholesterol esterase (TGL1)For more information on our capabilities and case studies, please contact us at info@enzymogenbio.com
Google AdSense
Google Cloud Hosting
Mobile Friendly